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Abstract
Background: The relationship between stroke risk and cognitive function has not previously been
examined in a large community living sample other than the Framingham cohort. The objective of
this study was to examine the relationship between 10-year risk for incident stroke and cognitive
function in a large population-based sample.
Methods: Participants were 7377 adults aged 50 years and over of the 2002 wave of the English
Longitudinal Study of Ageing, a prospective cohort study. A modified version of the Framingham
Stroke Risk Profile (incorporating age, sex, systolic blood pressure, antihypertensive medication,
diabetes, smoking status, cardiovascular disease, and atrial fibrillation) was used to assess 10-year
risk of stroke. Linear regression models were used to determine the cross-sectional relationship
of stroke risk to global cognitive function and performance in multiple cognitive domains.
Results:  In unadjusted models 10 percentage point increments of 10-year stroke risk were
associated with poor global cognitive function (-0.40 SD units, 95% CI -0.43 – -0.38), and lowered
performance in all cognitive domains. After statistical adjustment for age, sex, testing interval and
other correlates of cognitive function the association with stroke risk was attenuated though
remained significant for global cognitive function (-0.06 SD units, 95% CI -0.09 – -0.03), immediate
and delayed verbal memory, semantic verbal fluency and processing speed.
Conclusion:  In individuals free from a history of stroke or dementia, high subclinical
cerebrovascular disease burden was associated with worse cognitive function in multiple domains.
Background
Risk factors for incident stroke such as smoking status and
diabetes predispose older adults to brain atrophy, white
matter abnormalities and silent cerebral infarction in
addition to clinical stroke, [1-4] and biological aging of
the brain is partly attributable to aging of the cerebrovas-
cular circulation and the effects of these vascular changes
on the brain.[5,6] Differences in subclinical cerebrovascu-
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lar pathology may therefore help to explain the marked
individual differences in cognitive function and rate of
decline observed during late adulthood.[7,8] As Hachin-
ski recently noted, the relationship between subclinical
cerebrovascular pathology and cognition has effectively
been neglected, and provides a great opportunity for pre-
vention if implemented at the 'brain at risk' stage.[9]
Brady and colleagues[6] observed that the Framingham
Stroke Risk Profile (FSRP),[10,11] a previously validated
index of cerebrovascular disease burden, predicted 3-year
semantic verbal fluency decline. Their analyses incorpo-
rated 235 male Veterans Administration patients free of
stroke or dementia, and they controlled for age, educa-
tion, and baseline performance. However, they observed
no association between stroke risk and decline in memory
(including immediate and delayed verbal recall) or visual-
spatial function. They argued that stroke risk factors may
therefore have a particularly damaging effect on frontally
mediated cognitive functions (e.g. semantic verbal flu-
ency) in comparison with functions mediated by other
brain regions (e.g. memory). Their study was limited by
the small institutionalized male sample and the lack of
adjustment for additional correlates of cognition.
Elias and colleagues discovered significant associations
between a modified FSRP and a wide range of cognitive
abilities (abstract reasoning, visual-spatial memory, visual
organization, attention, visual scanning and tracking) in
1011 men and 1164 women free of dementia and stroke
from the Framingham Offspring Study.[12] However,
stroke risk was not significantly associated with verbal
memory or paired associate learning. They adjusted for
age, sex, education, depressed mood, alcohol consump-
tion, BMI, and total serum cholesterol in their full covari-
ate model.  The sample was largely composed of highly
educated individuals, and the authors argue that further
research is necessary to extend this work to a more repre-
sentative study population. Recent American Heart Asso-
ciation and the American Stroke Association Stroke
Council guidelines also stress the need for further research
using the FSRP with groups other than the Framingham
cohort.[13] Given that the main evidence linking stroke
risk and cognitive function incorporates the same sample
used for the development of the FSRP itself, further
research is clearly needed to examine whether this associ-
ation generalizes to an independent and more representa-
tive cohort.
We used a modified version of the FSRP to study the rela-
tionship between stroke risk and cognitive function. The
major risk factors for stroke are combined and weighted to
produce a convenient and cost-effective score that predicts
the 10-year probability of incident stroke in stroke-free
individuals. The FSRP is predictive of brain atrophy,[4]
which is in turn associated with an increased subsequent
risk of dementia.[14,15] The relationship between the
FSRP and cognition has not previously been examined in
a large population-based sample other than the Framing-
ham cohort itself. Our objective was to investigate
whether stroke risk was associated with cognitive function
in a large nationally representative population.
Methods
Subjects
Participants were from the 2002 wave of the English Lon-
gitudinal Study of Ageing (ELSA) who were born between
1901 and 1952.[16] Following ethical approval from the
Multicentre Research and Ethics Committee the ELSA
sample was drawn from households participating in the
Health Survey for England (HSE), a nationally represent-
ative multi-stage stratified random sample of the commu-
nity living English population. First, 1759 postcode
sectors (geographic areas) were selected from the Post-
code Address File, stratified by health authority and pro-
portion of households in non-manual socioeconomic
groups. Second, households were randomly selected, and
a specified number of adults and children were deemed
eligible for interview.  Households were included in ELSA
if one or more individuals living there was aged 50 or
over. 11392 individuals took part in the HSE and ELSA
and were eligible for the analysis. The final ELSA sample
contained 708 additional respondents who had joined
eligible households since HSE, though these individuals
were precluded from our analyses. Comparison with cen-
sus results suggests that the ELSA sample has the same
demographic profile as the English community living
population.[16]  Information on all FSRP components
was collected from a subsample of 7716 individuals. 339
(4%) participants with a history of clinical stroke or
dementia were excluded. The remaining 7377 participants
formed the sample for our analyses.
Stroke Risk Profile
The FSRP is a widely used clinical score based on the pre-
diction of 427 stroke events observed over a 10-year fol-
low up period for 2372 men and 3362 women in the
Framingham Heart Study.[10,11] The FSRP is based on
the following risk factors: age, systolic blood pressure,
antihypertensive medication, diabetes, cigarette smoking
status, history of cardiovascular disease, atrial fibrillation,
and left ventricular hypertrophy as determined by ECG.
Two of the FSRP components were determined from the
HSE (systolic blood pressure and antihypertensive medi-
cation use). Systolic blood pressure (mm Hg) was
recorded as the average of three nurse-recorded measure-
ments taken on the right arm with the informant in a
seated position after five minutes rest. The remaining
FSRP components were assessed at the 2002 wave of
ELSA. Diabetes was defined as a previous diagnosis of dia-BMC Neurology 2008, 8:12 http://www.biomedcentral.com/1471-2377/8/12
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betes or use of a hypoglycaemic agent or insulin. Partici-
pants were categorized as current cigarette smokers or not
by current cigarette smoking status. Previous diagnoses of
cardiovascular disease (defined here as coronary heart dis-
ease, congestive heart failure, or peripheral vascular dis-
ease) and atrial fibrillation were also incorporated.  We
did not incorporate left ventricular hypertrophy in the
present analysis as ECG data were not available. Risk of
stroke was defined as the 10-year risk or predicted proba-
bility of incident stroke expressed as a percentage.[11]
Levels of 10-year stroke risk ranged from 3% to 68% for
men and 1% to 84% for women.
Neuropsychological Test Battery
The neuropsychological tests incorporated in the 2002
wave of ELSA to assess cognition are summarized below
and described in detail elsewhere.[17] Time orientation
was assessed using questions from the Mini-Mental State
Examination (MMSE).[18] Immediate and delayed verbal
memory were assessed using a 10-word learning task from
the Health and Retirement Study (HRS).[19] Ten com-
mon words are presented aurally by computer at a rate of
one word every 2 seconds. The sound level is adjusted to
meet the requirements of each participant. Participants
are then asked to recall as many words as possible imme-
diately and again after a short delay during which they
complete other cognitive tests. Four different randomly
assigned word lists are used, and members of the same
household are given different versions.  Prospective mem-
ory (or 'remembering to remember') was assessed by ask-
ing participants to remember to write their initials in the
top left corner of a page of a clipboard when it is handed
to them later in the session (closely based on a task incor-
porated in the MRC Cognitive Function and Ageing Study
[MRC CFAS]),[20] and asking participants to remind the
interviewer to record the time when the interviewer
announces that the cognitive section is finished. Numer-
acy was assessed using questions relating to simple calcu-
lations based on everyday situations, and these items have
also been incorporated in the HRS.[19] The semantic ver-
bal fluency task was taken from the CAMCOG,[21] and
examines how many animals people are able to name in
one minute. The same task has been used in many other
studies, including MRC CFAS. Attention and processing
speed were assessed using the letter cancellation task from
the MRC National Study of Health and Development.[22]
Participants are asked to cross out as many of the 65 target
letters (P and W) as possible in 1 minute on a page incor-
porating 780 letters in a grid. The total number of letters
searched provides a measure of processing speed. The
ratio of correctly identified target letters to all target letters
scanned provides a measure of search accuracy. As the
scoring of each individual test varies, we standardized test
scores to give a mean of 0 and a standard deviation of 1
(z-scores). We obtained a global cognitive function score
by standardizing the summed z-scores on all neuropsy-
chological tests.
Statistical Analysis
Multivariable linear regression models were used to deter-
mine the relationship of 10-year stroke risk to cognitive
function and performance in multiple cognitive domains.
We first examined unadjusted models. To facilitate inter-
pretation we examined 10-year stroke risk (FSRP scores)
in 10 percentage point increments. For basic adjustment
we controlled for interval in years between blood pressure
measurement and cognitive testing, and those elements of
the FSRP that are not amenable to intervention (age and
sex). In full covariate models we added additional corre-
lates of cognitive function in order to examine whether
10-year stroke risk was independently predictive: educa-
tion (school leaving age in years), socioeconomic status
(based on National Statistics-socioeconomic classifica-
tion 3 based occupational categories: professional/mana-
gerial, intermediate, routine/manual),[23] total net non-
housing wealth, BMI (wt/ht2), alcohol consumption (g/
day), and depressive symptoms (> 3 depressive symptoms
on the 8-item Center for Epidemiological Studies Depres-
sion Scale [CESD]).[24,25] Analyses of FSRP components
were undertaken to further explore their independence as
risk factors. We conducted sensitivity analyses to adjust
for total serum cholesterol (mmol/L) for a subsample of
participants (n = 2746), and examine whether the same
pattern of associations was observed for those with and
without educational qualifications. Official ELSA weights
were used to adjust for the survey design.[16] All statistical
levels quoted (P values) are two-tailed. Data were ana-
lyzed using Stata SE version 9.2.[26]
Results
The characteristics of the study sample are described in
Table 1. Men had a significantly higher 10-year risk of
stroke than women, and were significantly younger than
women. A greater proportion of men had diabetes and
cardiovascular disease than women. Descriptive statistics
for the neuropsychological tests are presented in Table 2.
Women performed better on time orientation, immediate
verbal memory, delayed verbal memory, and processing
speed. Conversely men performed better on prospective
memory, semantic verbal fluency, and numeracy.
We used linear regression analyses to determine the rela-
tionship between 10-year stroke risk and global cognitive
function. In the unadjusted model 10-year stroke risk was
clearly associated with cognitive function (β  = -0.405,
95% CI -0.434 – -0.376, P < 0.001). In other words, for
every 10 percentage point increase in 10-year stroke risk
cognitive function worsens by 0.4 SD units. This associa-
tion was attenuated after adjustment for testing interval
and FSRP risk factors not amenable to intervention (ageBMC Neurology 2008, 8:12 http://www.biomedcentral.com/1471-2377/8/12
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and sex), though remained significant (β = -0.086, 95% CI
-0.117 – -0.056, P < 0.001). Similarly in the fully adjusted
model the association between stroke risk and cognitive
function remained significant (β = -0.057, 95% CI -0.089
– -0.025, P < 0.001). The association between stroke risk
and poor cognitive function observed was not simply due
to the associations with age, sex and additional variables
associated with cognition.






Framingham Stroke Risk Profile‡, % 10.5 (8.7) 9.5 (11.4) < 0.001
Stroke risk components
Mean age, y 64.0 (10.5) 65.6 (12.5) < 0.001
Mean systolic blood pressure§ mm Hg 141.6 (18.8) 141.6 (22.7) 0.961
Treatment with antihypertensive drugs§ % 29.9 29.2 0.600
History of diabetes, % 8.2 5.4 < 0.001
Current smoker, % 15.2 15.0 0.765
History of cardiovascular disease, % 14.0 9.3 < 0.001
History of atrial fibrillation, % 6.4 5.3 0.060
Additional variables
Education (leaving age, y), % < 0.001
< 15 23.1 24.7
15–17 58.2 59.9
> 17 18.7 15.5
Socioeconomic status||, % < 0.001
Managerial and professional 36.9 23.5
Intermediate 19.5 28.6
Routine and manual 43.6 48.0
Mean total net non-housing wealth, £ 96,161.4 (331,157.4) 82,419.7 (294,015.5) 0.034
Alcohol consumption§ % < 0.001
≥ 30 g/day 72.4 83.7
0.1–29.9 g/day 20.4 3.1
None 7.2 13.1
Mean BMI§ wt/ht2 27.7 (4.0) 27.5 (4.8) 0.143
Depressive symptoms (8-item CESD > 3), % 11.1 17.9 < 0.001
Mean total serum cholesterol§ mmol/L 4.6 (2.8) 4.8 (3.2) 0.030
CESD indicates Center for Epidemiological Studies Depression Scale. Values are mean (SD) where appropriate.
*339 persons with a history of stroke or dementia were excluded.
†P value for mean difference between men and women.
‡Excluding left ventricular hypertrophy.
§Variable derived from the Health Survey for England (HSE).
||Based on current or former occupation according to National Statistics-socioeconomic classification 3. [23]
Table 2: Neuropsychological Test Raw Scores*
Men (n = 3315) Women (n = 4062)
Cognitive Domain Range Mean SD Mean SD P†
Time orientation 0 – 4 3.67 0.69 3.73 0.61 < 0.001
Immediate verbal memory 0 – 10 5.38 1.76 5.50 1.75 0.002
Delayed verbal memory 0 – 10 3.92 2.08 4.07 2.11 0.001
Prospective memory 0 – 2 1.12 0.80 0.99 0.80 < 0.001
Semantic verbal fluency 0 – 8 19.94 6.39 18.83 6.20 < 0.001
Processing speed 0 – 780 295.26 92.71 317.30 96.11 < 0.001
Attention 0 – 1 0.79 0.14 0.79 0.14 0.957
Numeracy 0 – 6 4.31 1.35 3.58 1.33 < 0.001
*339 persons with a history of stroke or dementia were excluded.
†P value for mean difference between men and women.BMC Neurology 2008, 8:12 http://www.biomedcentral.com/1471-2377/8/12
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Performance in all individual cognitive domains was sig-
nificantly associated with stroke risk in unadjusted linear
regression models (Table 3). For example, each 10 per-
centage point increment in 10-year stroke risk was associ-
ated with a decrement of 0.355 SD for delayed verbal
memory. In the full covariate models stroke risk remained
significantly associated with immediate verbal memory,
delayed verbal memory, semantic verbal fluency, and
processing speed. As the range of values for prospective
memory and time orientation were limited to a small
number of discrete categories we calculated additional
ordered logistic regression models, though this made no
difference, and the pattern of results was not sensitive to
the choice of model.
In order to further investigate which individual risk factors
were driving the results, each of the FSRP components was
related to global cognitive function. In an unadjusted lin-
ear regression model all individual risk factors were
inversely and significantly related to cognitive function
(range, β = -0.152, P < 0.001 to β = -0.011, P = 0.03), with
the exception of sex which was not significantly associated
(β = 0.002, P = 0.904), and atrial fibrillation which was
positively and significantly associated (β  = 0.024, P  =
0.003). In an adjusted model (also incorporating educa-
tion, testing interval, socioeconomic status, total net non-
housing wealth, BMI, alcohol consumption and depres-
sive symptoms) age, diabetes, smoking, cardiovascular
disease and sex (males higher) were inversely and signifi-
cantly associated with cognitive function (range, β  = -
0.118, P < 0.001 to β = -0.031, P < 0.01). However, neither
systolic blood pressure (β = -0.005, P = 0.286) nor atrial
fibrillation (β = 0.015, P = 0.071) were significantly asso-
ciated with cognitive function in the adjusted model.
Finally, sensitivity analyses to examine the robustness of
our results showed that the same association between
stroke risk and cognitive function was observed when
total cholesterol was also adjusted for in a subsample of
participants. Analysing those with and without educa-
tional qualifications separately also showed the same pat-
tern of results. The association between stroke risk and




In a large population-based cohort of English men and
women with no prior history of dementia or stroke, we
found a 10 percentage point increase in 10-year stroke risk
was associated with a large decrement in global cognitive
function (-0.40 SD units), and poor performance all cog-
nitive domains. The association between stroke risk and
cognitive function was not simply a reflection of age and
sex as risk factors, lending support to the notion that the
aggressive treatment of cerebrovascular risk factors may be
effective in preserving cognitive health. In full covariate
models (adjusted for age, sex, testing interval, socioeco-
nomic status, total net non-housing wealth, BMI, alcohol
consumption, and depressive symptoms) stroke risk
remained significantly associated with global cognitive
function, immediate and delayed verbal memory, seman-
tic verbal fluency and processing speed.
Critique of methods
The strengths of our study include the large population-
based sample and the wide range of neuropsychological
tests incorporated. We used survey weights to adjust for
the complex sampling design, and comparison with cen-
sus results suggests that ELSA has the same demographic
profile as the English community living population.[16]
Practice or learning effects were not an issue as we exam-
ined the first administration of these tests. We were also
able to adjust for a wide range of potential confounders.
Table 3: Regression Coefficients Expressing Cognitive Function Decrements (in SD units) for Each 10 Percentage Point Increment in 
10-Year Risk of Stroke*
Unadjusted models Fully adjusted models†
Cognitive Domain β (95% CI) P β (95% CI) P
Time orientation -0.131 (-0.160 – -0.103) < 0.001 -0.022 (-0.058 – 0.014) 0.231
Immediate verbal memory -0.332 (-0.360 – -0.305) < 0.001 -0.037 (-0.073 – -0.001) 0.044
Delayed verbal memory -0.355 (-0.381 – -0.329) < 0.001 -0.064 (-0.097 – -0.032) < 0.001
Prospective memory -0.244 (-0.267 – -0.221) < 0.001 -0.026 (-0.059 – 0.007) 0.127
Semantic verbal fluency -0.276 (-0.300 – -0.252) < 0.001 -0.032 (-0.063 – -0.002) 0.038
Processing speed -0.185 (-0.212 – -0.157) < 0.001 -0.045 (-0.084 – -0.007) 0.022
Attention -0.167 (-0.194 – -0.141) < 0.001 -0.015 (-0.053 – 0.024) 0.449
Numeracy -0.181 (-0.206 – -0.157) < 0.001 -0.007 (-0.040 – 0.026) 0.683
Pooled data are shown as sex-specific analyses gave similar results. Persons with a history of stroke or dementia were excluded.
*Modified Framingham Stroke Risk Profile excluding left ventricular hypertrophy.
†Adjusted for age, sex, testing interval, education, socioeconomic status, total net non-housing wealth, BMI, alcohol consumption, and depressive 
symptoms.BMC Neurology 2008, 8:12 http://www.biomedcentral.com/1471-2377/8/12
Page 6 of 8
(page number not for citation purposes)
As many of the risk factors for poor cognition are also risk
factors for stroke,[9] this may have misleadingly attenu-
ated the relationship between stroke risk and cognitive
function. However, the inverse association observed
remained significant even in the full covariate model, sug-
gesting that stroke risk is robustly and independently
associated with levels of cognitive function.
Our analyses were restricted to community living individ-
uals. However, dementia is highly prevalent in institu-
tional care in England,[27] and as we excluded
individuals with a history of dementia many of these indi-
viduals would have been excluded. The possibility of
residual confounding and the cross-sectional design pre-
clude us from making definitive conclusions about causal-
ity, and the reliance on self-reported diagnosed medical
conditions (including stroke and dementia) is also a lim-
itation. There was evidence for a ceiling effect with the
time orientation questions, which may have attenuated
their association with the FSRP. As ECG data were not
available we did not incorporate left ventricular hypertro-
phy in the present analyses. However, the prevalence of
left ventricular hypertrophy is very low,[28] it is given lit-
tle weighting in the FSRP,[10,11] and the association
between left ventricular mass and cognition is rendered
non-significant after adjustment for cardiovascular risk
factors and cardiovascular disease.[29]
Results in comparison with literature
FSRP scores observed in the present analyses were higher
than those observed by Elias and colleagues,[12] as in
comparison the ELSA cohort was slightly older, had
higher mean systolic blood pressure, and a higher propor-
tion of current smokers. Our results are consistent with
their results suggesting that after adjustment for age, sex,
education and other correlates of cognition 10-year stroke
risk is associated with poor cognition in multiple
domains. These findings run contrary to a small longitu-
dinal study of institutionalized males.[6] suggesting that
the association between cognition and stroke risk is con-
fined to semantic verbal fluency (or frontally mediated
forms of cognition). It appears that stroke risk is associ-
ated with cognition in multiple cognitive domains, even
after adjustment for a wide range of potential confound-
ers.
Our findings are also consistent with a broader body of
research suggesting that individual risk factors for stroke
are associated with cognitive function.[9] While the neu-
ropsychological tests incorporated in our analyses differ
from those used by Elias and colleagues, both studies
included measures of processing speed that were associ-
ated with stroke risk in full covariate models. While we
observed an association with verbal memory, Elias and
colleagues did not. This may reflect differences in the ver-
bal memory tasks incorporated, as we incorporated a list
learning task and Elias and colleagues included a para-
graph recall task. Age, sex, education, BMI, alcohol con-
sumption, and depressive symptoms were adjusted for in
the full covariate models of both studies. Elias and col-
leagues adjusted for total serum cholesterol, while we
adjusted for this in a sensitivity analysis with a subsample
of individuals. Elias and colleagues' sample was largely
comprised of highly educated individuals, whereas the
ELSA sample is more diverse and shares the same sociode-
mographic profile as the community living population.
Our study therefore extends our understanding of the rela-
tionship between stroke risk and cognitive function by
demonstrating that it is not restricted to highly educated
individuals or the cohort used to develop the FSRP itself.
This study is also the first to incorporate additional adjust-
ment for socioeconomic status and wealth, which are well
established correlates of cognitive function.[30]
Subclinical cerebrovascular disease may provide an
important link between the major risk factors for stroke
and cognition. Brain atrophy, white matter abnormalities
and silent cerebral infarction are possible mechanisms
underlying the association between stroke risk and cogni-
tive function. [1-4] For example, the FSRP has been shown
to predict brain atrophy,[4] which is in turn associated
with an increased subsequent risk of dementia.[14,15] In
the population-based Rotterdam Scan Study white matter
hyperintensities, generalized brain atrophy, and brain inf-
arcts on MRI were associated with steeper decline in
processing speed and executive function during 5.2 years
mean follow-up.[31] After excluding participants with an
incident stroke several associations were no longer signif-
icant, suggesting that stroke risk is predictive of decline in
processing speed and executive function. Similarly, in a 3-
year prospective study of 554 subjects,[32] periventricular
white matter hyperintensity volume at baseline predicted
longitudinal decline in processing speed.
Conclusion
In summary, this is the first study to examine the relation-
ship between stroke risk and cognitive function in a large
population-based sample in a cohort other that that used
to develop the FSRP itself. Our findings are important as
they suggest that risk of stroke is robustly associated with
cognitive function in stroke- and dementia-free individu-
als, likely reflecting differences in subclinical cerebrovas-
cular pathology. Stroke risk remained significantly
associated with cognitive function in multiple domains
even after adjustment for a wide range of factors correlated
with cognition.
This association was observed in individuals with and
without educational qualifications. The FSRP may pro-
vide a convenient and cost-effective way to identify vul-BMC Neurology 2008, 8:12 http://www.biomedcentral.com/1471-2377/8/12
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nerable older adults at the 'brain at risk' stage,[9] and
further research is needed to establish whether the tar-
geted aggressive treatment of cerebrovascular risk factors
is an effective preventative strategy for cognitive decline.
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